Phase 1 Non Muscle Invasive Bladder Cancer Clinical Trials
10 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–10 of 10 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Non Muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC32 enrolled13 locationsNCT06637423
Recruiting
Phase 1Phase 2
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Non Muscle Invasive Bladder Cancer
SURGE Therapeutics75 enrolled20 locationsNCT05710848
Recruiting
Phase 1
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Non Muscle Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center55 enrolled7 locationsNCT05126472
Recruiting
Phase 1
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Non Muscle Invasive Bladder Cancer
Pfizer294 enrolled47 locationsNCT07206225
Recruiting
Phase 1
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Urothelial Carcinoma BladderNon Muscle Invasive Bladder CancerNMIBC+3 more
Aura Biosciences55 enrolled17 locationsNCT05483868
Recruiting
Phase 1Phase 2
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
Non Muscle Invasive Bladder Cancer
ImmunityBio, Inc.596 enrolled80 locationsNCT02138734
Recruiting
Phase 1
A Phase I Intravesical PPM Therapy for NMIBC
Non Muscle Invasive Bladder Cancer
VA Office of Research and Development29 enrolled1 locationNCT05519241
Recruiting
Phase 1
A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer
Non Muscle Invasive Bladder Cancer
The Affiliated Hospital of Xuzhou Medical University16 enrolled1 locationNCT06632964
Recruiting
Phase 1Phase 2
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
Non Muscle Invasive Bladder Cancer
Binhui Biopharmaceutical Co., Ltd.30 enrolled1 locationNCT05232136
Completed
Phase 1
SUBurothelial DUrvalumab injEction-1 (SUBDUE-1)
Muscle invasive or high risk non muscle invasive bladder cancer
South Metropolitan Health Service12 enrolled1 locationACTRN12620000063910